2018
DOI: 10.1152/ajpcell.00283.2017
|View full text |Cite
|
Sign up to set email alerts
|

Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer

Abstract: Some microRNAs (miRs) are dysregulated in cancers, and aberrant miR expression has been reported to correlate with chemoresistance of cancer cells. Therefore, the present study aims at investigating the effects of microRNA-139-5p (miR-139-5p) on cisplatin resistance of ovarian cancer (OC) with involvement of ring finger protein 2 (RNF2) and the mitogen-activated protein kinase (MAPK) signaling pathway. OC tissues were obtained from 66 primary OC patients. The cisplatin-sensitive A2780 and cisplatin-resistant A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
21
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(23 citation statements)
references
References 50 publications
(62 reference statements)
2
21
0
Order By: Relevance
“…24 Chen et al suggested that miR-139-5p overexpression combined with inactivation of the MAPK signaling pathway can reverse the cisplatin resistance of ovarian cancer by suppressing RNF2. 25 In the present study, we found that RNF2 expression was significantly increased in GC tissues and positively correlated with TNM stage and poor prognosis. Bioinformatic prediction and experimental verification showed that RNF2 served as a target of miR-149-3p in GC.…”
Section: Discussionsupporting
confidence: 58%
“…24 Chen et al suggested that miR-139-5p overexpression combined with inactivation of the MAPK signaling pathway can reverse the cisplatin resistance of ovarian cancer by suppressing RNF2. 25 In the present study, we found that RNF2 expression was significantly increased in GC tissues and positively correlated with TNM stage and poor prognosis. Bioinformatic prediction and experimental verification showed that RNF2 served as a target of miR-149-3p in GC.…”
Section: Discussionsupporting
confidence: 58%
“…microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. MiR-139-5p, located on chromosome 11q13.4, has been reported to play important roles in many cancers [30][31][32][33]. In our study, we found that miR-139-5p expression in liver ranked the third among 21 organs in clinical samples, and usually was decreased in tumors.…”
Section: Discussionsupporting
confidence: 50%
“…Recent studies reported that RNF2 is highly expressed in malignant tumors and serves a role in promoting cancer (28,29). For example, previous studies demonstrated that RNF2 protein is highly expressed in esophageal, pancreatic, bladder, breast and ovarian cancers, and that RNF2 is manly located in tumor cell nucleus (11,30,31). Yang et al (16) reported a significantly higher RNF2 protein expression in esophageal cancer compared with adjacent tissue, which was associated with tumor size, tumor-node-metastasis (TNM) stage and lymph node metastasis; however, RNF2 expression is not associated with the prognosis of patients.…”
Section: Discussionmentioning
confidence: 99%